EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC 4.0

Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn’s Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?

Iago Rodríguez-Lago, José Ignacio Peinado-Fabregat, Marcelo Guigini, Mónica Cerezales, Francisco Ibáñez, Carlos Crespo, Manuel Barreiro-de Acosta

PharmacoEconomics - Open · 2026-05 · 10 (3) · 591-591

DOI: 10.1007/s41669-026-00648-9 ↗

Kurz gefasst

Korrektur in der Zeitschrift PharmacoEconomics - Open, online erschienen am 21.04.2026. Verfasst von Iago Rodríguez-Lago und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Hospital Universitario de Galdakao, Galdakao, Spain. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Gastroenterology Department, Hospital Universitario de Galdakao, Galdakao, Spain.
  • Biobizkaia Health Research Institute, Barakaldo, Spain.
  • Faculty of Health Sciences, Deusto University, Bilbao, Spain.
  • Fresenius Kabi España, S.A.U., Barcelona, Spain.
  • Axentiva Solutions S.L., Oviedo, Spain.
  • Axentiva Solutions S.L., Barcelona, Spain. fibanez@axentiva.com.

Zitieren

APA

Rodríguez-Lago, I., Peinado-Fabregat, J. I., Guigini, M., Cerezales, M., Ibáñez, F., Crespo, C., & Barreiro-de Acosta, M. (2026). Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn’s Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?. PharmacoEconomics - Open, 10(3), 591-591. https://doi.org/10.1007/s41669-026-00648-9

Vancouver

Rodríguez-Lago I, Peinado-Fabregat JI, Guigini M, Cerezales M, Ibáñez F, Crespo C, et al. Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn’s Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?. PharmacoEconomics - Open. 2026;10(3):591-591. doi:10.1007/s41669-026-00648-9

BibTeX
@article{RodrguezLago2026,
  author = {Rodríguez-Lago, Iago and Peinado-Fabregat, José Ignacio and Guigini, Marcelo and Cerezales, Mónica and Ibáñez, Francisco and Crespo, Carlos and Barreiro-de Acosta, Manuel},
  title = {Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn’s Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?},
  journal = {PharmacoEconomics - Open},
  year = {2026},
  volume = {10},
  number = {3},
  pages = {591--591},
  doi = {10.1007/s41669-026-00648-9}
}
Kostenlos starten →